Drug Profile
NT 3 gene therapy
Alternative Names: Neurotrophin 3 gene therapyLatest Information Update: 18 Jul 2006
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Gene therapies
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Motor neuron disease